Literature DB >> 26462785

[Bortezomib-based four-drug combination regimen improved the efficacy of multiple myeloma patients receiving previous doublet or triplet regimens containing Bortezomib].

Junru Liu1, Juan Li1, Dong Zheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26462785     DOI： 10.3760/cma.j.issn.0253-2727.2015.09.017

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs.

Authors:  Jun Zhang; Wenju Lu; Yuqin Chen; Qian Jiang; Kai Yang; Meichan Li; Ziyi Wang; Xin Duan; Lei Xu; Haiyang Tang; Dejun Sun; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-13       Impact factor: 4.249

2.  [Bortezomib-based treatment of 26 cases multiple myeloma complicating with intestinal obstruction].

Authors:  Q L Zhang; Y Z Liu; Q D Lin; L N Liu; Z Y Mei; M L Nie; Y P Song; B J Fang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.